Clinical Trial

Gentle Touch for Post-Mastectomy Lymphedema

Study acronym: GT-BCRL
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This is a single-blind, parallel-group Randomized Controlled Trial (RCT) comparing the efficacy of a specialized manual technique, Gentle Touch (GT), versus a control intervention, both added to the usual rehabilitative care. The study investigates 36 women aged 30 to 75 with Breast Cancer-Related Lymphedema (BCRL). The primary objective is to evaluate the reduction of lymphedema volume in the upper limb. Secondary objectives include assessing the improvement in patients' quality of life and the potential reduction in care burden and costs. The treatment protocol involves 10 bi-weekly sessions over 5 weeks.
Trial Details
NCT Number NCT07257679
Lead Sponsor I.R.C.C.S. Fondazione Santa Lucia
Collaborators: Comitato A.N.D.O.S. di Roma odv.
Conditions Lymphedema, Breast Cancer
Enrollment 36 participants
Start Date 2025-11-01
Primary Completion 2027-01-15 (estimated)
Study Completion 2027-11-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-02